Exalenz Bioscience Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0011048688
Medical Equipment, Supplies & Distribution
Sales 2018 | 13.14M 3.55M 1.31B 296M | Sales 2019 | 14.04M 3.79M 1.4B 316M | Capitalization | 77.67M 20.96M 7.77B 1.75B |
---|---|---|---|---|---|
Net income 2018 | -5M -1.35M -500M -112M | Net income 2019 | -1M -270K -100M -22.5M | EV / Sales 2018 | 15.2 x |
Net Debt 2018 | 2.93M 790K 293M 65.85M | Net Debt 2019 | 3.09M 835K 309M 69.59M | EV / Sales 2019 | 5.75 x |
P/E ratio 2018 |
-34.6
x | P/E ratio 2019 |
-40
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 24.36% |
Managers | Title | Age | Since |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01/10/01 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29/19/29 |
Eitan Blank
COO | Chief Operating Officer | 54 | 01/07/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04/16/04 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01/06/01 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16/15/16 |
1st Jan change | Capi. | |
---|---|---|
-3.79% | 184B | |
-0.84% | 107B | |
-3.75% | 69.44B | |
+3.45% | 50.37B | |
+9.04% | 44.82B | |
+3.40% | 41.53B | |
+3.66% | 26.84B | |
+3.21% | 26.73B | |
+15.23% | 25.71B |